P. Nouyrigat
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study.(1996)
- → Phase II trial evaluating a docetaxel‐capecitabine combination as treatment for hormone‐refractory prostate cancer(2006)33 cited
- → BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study(2014)22 cited
- → Osteosarcoma with calcified regional lymph nodes(1993)16 cited
- → Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines(2011)14 cited
- Candida arthritis treated with intra-articular amphotericin B.(1993)
- → Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study(2004)8 cited
- → Soluble epidermal growth factor receptor (EGFR) and HER-2 monitoring in a Phase II combination of gefitinib (ZD1839) and docetaxel for non-small-cell lung cancer (NSCLC)(2004)6 cited
- → A combination docetaxel-capecitabine in patients (pts) with hormone refractory advanced prostate cancer(2004)4 cited
- → Neoadjuvant weekly paclitaxel, and epirubicin (PE) in patients with inflammatory and T4 breast cancer (IBC-T4BC): Result of a VAR Cancer Society tria(2004)4 cited